International Journal of Human Research and Social Science Studies

The study examines how families seeking medical cannabis for children with treatment-resistant epilepsy drive transformative change in medical paradigms and healthcare systems. Through interviews with nine parents, researchers identified how these families' experiences challenge conventional treatment approaches while demonstrating cannabis's efficacy in reducing seizures and improving quality of life. Our research reveals a consistent pattern: parents transition from desperate treatment-seekers to knowledgeable advocates as they navigate complex medical, legal, and regulatory barriers. Many families relocate as "medical refugees," sacrificing careers and support networks to access treatment. The findings highlight three dominant themes: the stark contrast between conventional treatments and cannabis efficacy, parents' evolution into system navigators and advocates, and the formation of supportive medical cannabis communities that facilitate knowledge sharing and collective action. These interconnected themes illustrate how grassroots patient advocacy can reshape medical practice and public policy when established systems prove inadequate.

alternative medicine, medical cannabis, medical refugees, patient advocacy, pediatric epilepsy, seizures, treatment-resistant epilepsy

1. Bronfenbrenner, U. (1977). Toward an experimental ecology of human development. American Psychologist, 32(7), 513-531. https://doi.org/10.1037/0003-066X
2. Chen, K., Farrar, M.A., Cardamone, M., & Lawson, J.A. (2018). Cannabis for paediatric epilepsy: challenges and conundrums. Medical Journal of Australia, 208(3). https://www.dalgarnoinstitute.org.au/images/resources/pdf/cannabis-medical-use/Cannabis_for_paediatric_epilepsy_-_challenges_and_conundrums.pdf
3. Elliott, J., DeJean, D., Clifford, T., Coyle, D., Potter, B.K., Skidmore, B., Alexander, C., Repetski, A.E., McCoy, B., & Wells, G.A. (2018). Cannabis for pediatric epilepsy: protocol for a living systematic review. Systematic Reviews, 7. https://doi.org/10.1186/s13643-018-0761-2
4. Erridge, S., Holvey, C., Coomber, R., Hoare, J., Khan, S., Platt, M. W., Rucker, J. J., Weatherall, M. W., Beri, S., & Sodergren, M. H. (2022). Clinical outcome data of children treated with cannabis-based medicinal products for treatment-resistant epilepsy: Analysis from the UK Medical Cannabis Registry. Neuropediatrics, 54(03), 174–181. https://doi.org/10.1055/a-2002-2119
5. Gibbard, M., Mount, D., Rassekh, S. R., & Side, H. (2021). Family attitudes about and experiences with medical cannabis in children with cancer or epilepsy: an exploratory qualitative study. CMAJ Open, 9(2), 563-569. https://doi.org/10.9778/cmajo.20200212
6. Hausman-Kedem, M., Menascu, S., & Kramer, U. (2018). Efficacy of CBD-enriched medical cannabis for treatment of refractory epilepsy in children and adolescents – An observational, longitudinal study. Brain and Development, 40, 544-551. https://doi.org/10.1016/j.braindev.2018.03.013
7. Huntsman, R.J., Tang-wai, R., & Shackelford, A.E. (2020). Cannabis for pediatric epilepsy. Journal of clinical neurophysiology: Official publication of the American Electroencephalographic Society, 37(1), 2-8. https://doi.org/10.1097/WNP.0000000000000641
8. Libzon, S., Schleider, L.B., Saban, N., Levit, L., Tamari, Y., Linder, I., Lerman-Sagie, T., & Blumkin, L. (2018). Medical cannabis for pediatric moderate to severe complex motor disorders. Journal of Child Neurology, 33, 565 - 571. https://doi.org/10.1177/0883073818773028
9. Lorentzos, M.S., & Webster, R.I. (2015). Cannabinoids for paediatric epilepsy: Weeding out the issues. Journal of Paediatrics and Child Health, 51. https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jpc.12877
10. Neale, M. (2017). Efficacy and safety of cannabis for treating children with refractory epilepsy. Nursing Children and Young People, 29(7), 32-37. doi: 10.7748/ncyp.2017.e907
11. Porter, B. E., & Jacobson, C. (2013). Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy. Epilepsy & Behavior, 29(3), 574–577. http://doi.org/10.1016/j.yebeh.2013.08.037
12. Rosenberg, E.C., Louik, J., Conway, E.M., Devinsky, O., & Friedman, D. (2017). Quality of life in childhood epilepsy in pediatric patients enrolled in a prospective, open‐label clinical study with cannabidiol. Epilepsia, 58, 96-100. https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/epi.13815
13. Ryan, J.E., Smeltzer, S.C., & Sharts‐Hopko, N.C. (2020). Parents' experiences using medical cannabis for their child. Nursing Outlook, 68(3), 337-344. https://doi.org/10.1016/j.outlook.2019.12.004
14. Saldaña, J. (2021). The coding manual for qualitative researchers (4th ed.). Thousand Oaks, CA: Sage Publications.
15. Sholz, R.W. (1983). Introduction to decision making under uncertainty: Biases, fallacies, and the development of decision making. Advances in Psychology, 16, 3-18. https://doi.org/10.1016/S0166-4115(08)62191-3
16. Sobo, E. J. (2017). Parent use of cannabis for intractable pediatric epilepsy: Everyday empiricism and the boundaries of scientific medicine. Social Science & Medicine, 190. 190-198. https://doi.org/10.1016/j.socscimed.2017.08.003
17. Sousa, T., Rodrigues, B., Colaço, P., Remígio, A.V., Fernandes, C., Silva, S., Lacerda, T., Melo Neto, A., Silva, J., & Souza, B. (2023). The impact of cannabidiol on epileptic children’s quality of life. Residência Pediátrica, 13(1).
18. Tzadok, M., Uliel-Siboni, S., Linder, I., Kramer, U., Epstein, O., Menascu, S., Nissenkorn, A., Yosef, O.B., Hyman, E.R., Granot, D., Dor, M.B., Lerman-Sagie, T., & Ben-Zeev, B. (2016). CBD-enriched medical cannabis for intractable pediatric epilepsy: The current Israeli experience. Seizure, 35, 41-44. http://www.seizure-journal.com/article/S1059131116000054/pdf
19. Voronka, J. (2016). The politics of ‘people with lived experience’ experiential authority and the risks of strategic essentialism. Philosophy, Psychiatry, & Psychology, 23(3/4), 189-201. https://doi.org/10.1353/ppp.2016.0017
20. Zafar, R., Schlag, A.K., Phillips, L., & Nutt, D.J. (2021). Medical cannabis for severe treatment resistant epilepsy in children: a case-series of 10 patients. BMJ Paediatrics Open, 5. https://bmjpaedsopen.bmj.com/content/bmjpo/5/1/e001234.full.pdf
21. Zafar, R., Schlag, A., & Nutt, D.J. (2020). Ending the pain of children with severe epilepsy? An audit of the impact of medical cannabis in 10 patients. Drug Science, Policy and Law, 6. https://journals.sagepub.com/doi/pdf/10.1177/2050324520974487